Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
L3Harris
LHX
|
+$148M |
| 2 |
GE HealthCare
GEHC
|
+$118M |
| 3 |
Atlassian
TEAM
|
+$101M |
| 4 |
Axon Enterprise
AXON
|
+$23.7M |
| 5 |
Reliance Steel & Aluminium
RS
|
+$22.4M |
Top Sells
| 1 |
Apple
AAPL
|
+$360M |
| 2 |
Microsoft
MSFT
|
+$199M |
| 3 |
GE Aerospace
GE
|
+$131M |
| 4 |
NVIDIA
NVDA
|
+$99.2M |
| 5 |
Amazon
AMZN
|
+$85.4M |
Sector Composition
| 1 | Technology | 28.64% |
| 2 | Healthcare | 14.81% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Industrials | 9.44% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Standex International
SXI
$2.47B
| $3.17M | ﹤0.01% |
25,900
-3,000
| -10% | -$367K |
|
1552
Valaris
VAL
$3.71B
| $3.17M | ﹤0.01% |
48,700
-5,700
| -10% | -$371K |
|
1553
Travere Therapeutics
TVTX
$2.09B
| $3.16M | ﹤0.01% |
140,700
+9,400
| +7% | +$211K |
|
1554
LiveRamp
RAMP
$1.73B
| $3.15M | ﹤0.01% |
143,500
-18,700
| -12% | -$410K |
|
1555
NovaGold Resources
NG
$2.82B
| $3.14M | ﹤0.01% |
508,200
-57,900
| -10% | -$358K |
|
1556
Ironwood Pharmaceuticals
IRWD
$213M
| $3.13M | ﹤0.01% |
298,000
-35,000
| -11% | -$368K |
|
1557
Northwest Bancshares
NWBI
$1.83B
| $3.13M | ﹤0.01% |
260,400
-30,600
| -11% | -$368K |
|
1558
Enerpac Tool Group
EPAC
$2.3B
| $3.13M | ﹤0.01% |
122,800
-17,600
| -13% | -$449K |
|
1559
Amphastar Pharmaceuticals
AMPH
$1.3B
| $3.13M | ﹤0.01% |
83,400
-11,200
| -12% | -$420K |
|
1560
Astrana Health
ASTH
$1.38B
| $3.12M | ﹤0.01% |
85,644
-9,700
| -10% | -$354K |
|
|
HEES
1561
DELISTED
H&E Equipment Services
HEES
| $3.12M | ﹤0.01% |
70,600
-7,900
| -10% | -$349K |
|
1562
Remitly
RELY
$3.74B
| $3.12M | ﹤0.01% |
184,200
-18,700
| -9% | -$317K |
|
1563
NBT Bancorp
NBTB
$2.27B
| $3.12M | ﹤0.01% |
92,500
-10,900
| -11% | -$367K |
|
1564
ACV Auctions
ACVA
$1.72B
| $3.12M | ﹤0.01% |
241,300
-22,900
| -9% | -$296K |
|
1565
Krystal Biotech
KRYS
$4.16B
| $3.11M | ﹤0.01% |
38,900
-4,500
| -10% | -$360K |
|
1566
Delek US
DK
$1.68B
| $3.11M | ﹤0.01% |
135,391
-19,000
| -12% | -$436K |
|
|
CGAU
1567
Centerra Gold
CGAU
$1.88B
| $3.1M | ﹤0.01% |
479,900
-52,800
| -10% | -$341K |
|
|
GTY
1568
Getty Realty Corp
GTY
$1.6B
| $3.09M | ﹤0.01% |
85,709
-10,200
| -11% | -$368K |
|
1569
Trustmark
TRMK
$2.43B
| $3.09M | ﹤0.01% |
125,000
-15,400
| -11% | -$380K |
|
|
MDRX
1570
DELISTED
Veradigm Inc. Common Stock
MDRX
| $3.08M | ﹤0.01% |
235,900
-31,600
| -12% | -$412K |
|
|
LTC
1571
LTC Properties
LTC
$1.67B
| $3.07M | ﹤0.01% |
87,462
-10,300
| -11% | -$362K |
|
1572
Dave & Buster's
PLAY
$817M
| $3.06M | ﹤0.01% |
83,273
-11,200
| -12% | -$412K |
|
1573
Herbalife
HLF
$986M
| $3.06M | ﹤0.01% |
190,172
-44,200
| -19% | -$712K |
|
|
TWO
1574
Two Harbors Investment
TWO
$1.05B
| $3.06M | ﹤0.01% |
207,988
+100
| +0% | +$1.47K |
|
1575
Q2 Holdings
QTWO
$5.13B
| $3.06M | ﹤0.01% |
124,200
-14,200
| -10% | -$350K |
|